5.58
price down icon1.64%   -0.093
after-market After Hours: 5.58
loading
Eupraxia Pharmaceuticals Inc stock is traded at $5.58, with a volume of 5,589. It is down -1.64% in the last 24 hours and up +5.28% over the past month. Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
See More
Previous Close:
$5.673
Open:
$5.56
24h Volume:
5,589
Relative Volume:
0.40
Market Cap:
$200.64M
Revenue:
-
Net Income/Loss:
$-25.50M
P/E Ratio:
-7.2468
EPS:
-0.77
Net Cash Flow:
$-30.10M
1W Performance:
+8.77%
1M Performance:
+5.28%
6M Performance:
+95.10%
1Y Performance:
+97.87%
1-Day Range:
Value
$5.55
$5.58
1-Week Range:
Value
$5.06
$5.69
52-Week Range:
Value
$2.20
$6.1999

Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile

Name
Name
Eupraxia Pharmaceuticals Inc
Name
Phone
-
Name
Address
-
Name
Employee
33
Name
Twitter
Name
Next Earnings Date
2024-08-09
Name
Latest SEC Filings
Name
EPRX's Discussions on Twitter

Compare EPRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
EPRX
Eupraxia Pharmaceuticals Inc
5.58 203.37M 0 -25.50M -30.10M -0.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-24-25 Initiated Cantor Fitzgerald Overweight
Jun-26-25 Initiated H.C. Wainwright Buy
Jun-16-25 Initiated Canaccord Genuity Speculative Buy
Feb-21-25 Initiated Craig Hallum Buy
Nov-14-24 Initiated Rodman & Renshaw Buy

Eupraxia Pharmaceuticals Inc Stock (EPRX) Latest News

pulisher
Jul 29, 2025

Eupraxia Pharmaceuticals Inc. stock daily chart insightsFree Profit Target Stock Opportunity Monitor - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Signal strength of Eupraxia Pharmaceuticals Inc. stock in tech scannersFree Price Action Based Buy Opportunity List - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why Eupraxia Pharmaceuticals Inc. stock attracts strong analyst attentionPrice Forecast Based on AI Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How Interest Rate Changes Impact Eupraxia Pharmaceuticals Inc. Stock PerformanceGrowth Watchlist for Long Term Positioning - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What high frequency data says about Eupraxia Pharmaceuticals Inc.Yearly Trend Summary and Opportunity Breakdown - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Is Eupraxia Pharmaceuticals Inc. stock a growth or value playBuy and Exit Strategy Based on Momentum - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why did EPRX's Q4 2024 earnings report show no surprise? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 10:20:51 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Using Bollinger Bands to evaluate Eupraxia Pharmaceuticals Inc.Free Step-by-Step Stock Investment Guide - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Is Eupraxia Pharmaceuticals Inc. forming a bottoming baseWeekly Price Target Forecast and Alerts - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How volatile is Eupraxia Pharmaceuticals Inc. stock compared to the marketAchieve consistent double-digit returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Cantor Fitzgerald Forecasts EPRX FY2025 Earnings - Defense World

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Eupraxia Pharmaceuticals Inc. stock attracting strong analyst attentionConsistent double returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Eupraxia Pharmaceuticals Inc. stockFree Investment Risk Control - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How does Eupraxia Pharmaceuticals Inc. generate profit in a changing economyGet professional guidance for market timing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Eupraxia Pharmaceuticals Inc. Stock a Good Fit for Conservative InvestorsLow Risk High Reward Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Eupraxia Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowHigh Return Setup Scanner - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Eupraxia Pharmaceuticals Inc. stock price move sharplyGrowth Optimized Stock Radar - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives $11.00 Average Target Price from Analysts - Defense World

Jul 27, 2025
pulisher
Jul 26, 2025

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Coverage Initiated at Cantor Fitzgerald - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Is Eupraxia Pharmaceuticals Inc. a good long term investmentFree Trend-Following Techniques - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Eupraxia Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Eupraxia Pharmaceuticals Inc. stock priceExplosive earning power - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

(EPRX.WT.A) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Eupraxia Pharmaceuticals Inc. stockHigh-yield capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

(EPRX) Market Dynamics and Trading Signals (EPRX:CA) - news.stocktradersdaily.com

Jul 23, 2025
pulisher
Jul 22, 2025

Eupraxia Pharmaceuticals to Present at Key Investor Conferences - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Eupraxia Pharmaceuticals Secures Speaking Slots at Canaccord, Citi, Cantor, and H.C. Wainwright Conferences - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

(EPRX.WT.A) Market Dynamics and Trading Signals - news.stocktradersdaily.com

Jul 21, 2025

Eupraxia Pharmaceuticals Inc Stock (EPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Cap:     |  Volume (24h):